Janus Henderson Group PLC
- SEC CIK
- 0001274173
- Latest filing
- May 18, 2026
INDV holding history
Indivior Pharmaceuticals, Inc. in every 13F filed by Janus Henderson Group PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INDV overviewAll 13F holders of INDVFull Q1 2026 holdings
- Shares (Q1 2026)
- 49,450
- Value
- $1.51M
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 49,450 | $1.51M | <0.1% | +13,500+37.6% | Added | Holders |
| Q4 2025 | 35,950 | $1.29M | <0.1% | −41,025−53.3% | Reduced | Holders |
| Q3 2025 | 76,975 | $1.86M | <0.1% | +76,975 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −40,546−100.0% | Sold out | Holders |
| Q1 2025 | 40,546 | $385.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 40,546 | $520.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 40,546 | $400.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 40,546 | $635.8K | <0.1% | −399,575−90.8% | Reduced | Holders |
| Q1 2024 | 440,121 | $9.42M | <0.1% | +54,750+14.2% | Added | Holders |
| Q4 2023 | 385,371 | $5.82M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 385,371 | $8.37M | <0.1% | +385,371 | New | Holders |